NASDAQ · ALGT

Allegiant Travel Company

$99.14 +$1.06 (+1.08%) 1D Pre-market

Key Metrics

$2.64B
Market cap
254.06×
P/E · TTM
$33.36M
Revenue · TTM
$10.38M
Net income
EPS · TTM $0.58
Dividend yield
Free cash flow
Beta · 1Y 2.23
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 20
    The stock moved +10.3% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 20
  • May 19
    From its Feb 6 high, the share price fell 39%.

    Peak close $114.79 on Feb 6; trough close $69.87 on May 19. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -39%
  • Feb 6
    The stock moved +15.5% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 6

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$2.64B
Enterprise value$3.49B
Shares outstanding26.9M
52-wk range$42.56 – $123.63
Avg volume · 20D307.5K
Net cash −$858.28M
Book value / share$60.95
IndustryAir Transportation, Scheduled
ExchangeNASDAQ
About Allegiant Travel Company
IPO dateDec 8, 2006
Employees5666

Allegiant Travel Co is a leisure travel company focused on providing travel and leisure services and products to residents of underserved cities in the United States.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E254.06
P/S79.03
P/FCF
EV/EBITDA
EV/Sales104.76
Graham №$28.13

Profitability

Gross
Operating 72.2%
Net 31.1%
FCF
ROE / ROIC 0.9% · —

Financial Health

Current ratio0.91
Quick ratio
Debt / equity1.63
Debt / EBITDA
Net cash −$858.28M
Working capital−$111.22M

Cash Flow · TTM

Operating CF
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

0 / 9
Weak fundamentals · 0 of 9 signals passing

Altman Z-Score

0.8
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

$28.13 vs $99.14
Trades 3.5× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings